Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Onglyza Resulted in Heart Failure Diagnosis, Lawsuit Alleges March 20, 2018 Irvin Jackson Add Your Comments Following more than two years of treatment wit Onglyza and Kombiglyze XR, a lawsuit filed by the family of an Ohio man indicate that side effects of the diabetes drug resulted in a heart failure diagnosis. The complaint (PDF) was filed late last month in the U.S. District Court for the Southern District of Ohio by Diana Lawrence, on behalf of herself and as personal representative for Thomas Lawrence, who allegedly developed heart failure, congestive heart failure and cardiovascular injury due to side effects of Onglyza and Kombiglyze XR. Onglyza (saxagliptin) was developed jointly by AstraZeneca and Bristol Myers Squibb, and introduced in 2009 for treatment of type 2 diabetes. Kombilgyze XR is an extended release version of the medication, which combines saxagliptin with the older diabetes drug metformin. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Although the drugs have been marketed as safe and effective, concerns have emerged in recent years about Onglyza heart failure risks, resulting in stronger warnings being required by the FDA last year. Thomas Lawrence was prescribed Onglyza and Kombiglyze XR at various times from July 2012 through October 2014, for the treatment of diabetes. The lawsuit alleges that AstraZeneca and Bristol Myers Squibb provided false and misleading information about the safety of saxagliptin contained in the medications, failing to adequately warn consumers and the medical community about the risk of a heart failure diagnosis. An investigation into the potential heart risks with Onglyza was first launched by the FDA in 2014, following the publication of a study, known as “SAVOR”, in the New England Journal of Medicine in 2013. “At no time did Defendants perform adequate safety testing on Saxagliptin prior to marketing their drugs to the American public and failed to do so until performing the SAVOR trial,” the lawsuit notes. “Despite the findings of the SAVOR trial, Defendants still have not undertaken efforts to change the labels and reference materials for Saxagliptin to include a reference or warning regarding heart failure, congestive heart failure, cardiac failure, and death related to those events.” In April 2015, the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted 14-1 to recommend stronger warnings about the potential Onglyza heart side effects, after a review of data from clinical trials suggested that users may face a higher than expected risk of hospitalization for heart failure and all-cause mortality. The review looked at two large clinical trials involving patients with heart disease. In both trials, patients given drugs containing saxagliptin or alogliptin were at a higher risk of being hospitalized for heart failure than those given a placebo. Lawrence’s claim joins a growing number of similar Onglyza lawsuits filed by individuals nationwide who say they developed heart failure or other health problems due to the lack of adequate warnings on the diabetes drug. On February 2, the U.S. Judicial Panel on Multidistrict Litigation consolidated all Onglyza cases in the U.S. District Court for the Eastern District of Kentucky, as part of a federal MDL, or multidistrict litigation, where they will undergo coordinated pretrial proceedings under District Judge Karen K. Caldwell. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: AstraZeneca, Bristol Myers Squibb, Diabetes, Diabetes Drug, Heart Failure, Kombiglyze XR, Onglyza Image Credit: | More Onglyza Lawsuit Stories Heart Failure Lawsuit Filed Against Makers Of Onglyza November 19, 2018 Judge Splits Discovery in Onglyza Heart Failure Cases Into Two Phases November 1, 2018 Drug Makers Want Plaintiffs To Prove Link Between Onglyza and Heart Failure Before Claims Proceed October 19, 2018 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: today) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025) MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: yesterday) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025) Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: 2 days ago) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Drug Makers Want Plaintiffs To Prove Link Between Onglyza and Heart Failure Before Claims Proceed October 19, 2018
Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: today) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)
MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: yesterday) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025)
Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: 2 days ago) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)